206 related articles for article (PubMed ID: 20067805)
21. Binding of the lipocalin C8gamma to human complement protein C8alpha is mediated by loops located at the entrance to the C8gamma ligand binding site.
Chiswell B; Slade DJ; Sodetz JM
Biochim Biophys Acta; 2006 Sep; 1764(9):1518-24. PubMed ID: 16935577
[TBL] [Abstract][Full Text] [Related]
22. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
24. Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).
Aleshin AE; Schraufstatter IU; Stec B; Bankston LA; Liddington RC; DiScipio RG
J Biol Chem; 2012 Mar; 287(13):10210-10222. PubMed ID: 22267737
[TBL] [Abstract][Full Text] [Related]
25. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
26. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.
Hallström T; Uhde M; Singh B; Skerka C; Riesbeck K; Zipfel PF
PLoS One; 2015; 10(9):e0137630. PubMed ID: 26368530
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
Huang Y; Fedarovich A; Tomlinson S; Davies C
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization and expression analysis of complement component C9 gene in the whitespotted bambooshark, Chiloscyllium plagiosum.
Wang Y; Xu S; Su Y; Ye B; Hua Z
Fish Shellfish Immunol; 2013 Aug; 35(2):599-606. PubMed ID: 23684808
[TBL] [Abstract][Full Text] [Related]
30. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).
Chauhan AK; Moore TL
Clin Exp Immunol; 2006 Sep; 145(3):398-406. PubMed ID: 16907906
[TBL] [Abstract][Full Text] [Related]
31. Immune role of the complement component 6 gene and its associated novel miRNA, miR-727, in half-smooth tongue sole (Cynoglossus semilaevis).
Ma H; Chen Y; Yu M; Chen X; Qi L; Wei S; Fan Q; Xu Q; Zhan M; Sha Z
Dev Comp Immunol; 2021 Oct; 123():104156. PubMed ID: 34077766
[TBL] [Abstract][Full Text] [Related]
32. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
33. Molecular cloning of the seventh component of complement in rainbow trout.
Zarkadis IK; Duraj S; Chondrou M
Dev Comp Immunol; 2005; 29(2):95-102. PubMed ID: 15450749
[TBL] [Abstract][Full Text] [Related]
34. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
35. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
36. Supported Lipid Bilayer Platform To Test Inhibitors of the Membrane Attack Complex: Insights into Biomacromolecular Assembly and Regulation.
Yorulmaz S; Jackman JA; Hunziker W; Cho NJ
Biomacromolecules; 2015 Nov; 16(11):3594-602. PubMed ID: 26444518
[TBL] [Abstract][Full Text] [Related]
37. Birth and death in terminal complement pathway.
Sharma A; Gupta S; Patil AB; Vijay N
Mol Immunol; 2022 Sep; 149():174-187. PubMed ID: 35908437
[TBL] [Abstract][Full Text] [Related]
38. Regulation of complement membrane attack complex formation in myocardial infarction.
Väkevä A; Laurila P; Meri S
Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
[TBL] [Abstract][Full Text] [Related]
39. A novel prolactin-like protein (PRL-L) gene in chickens and zebrafish: cloning and characterization of its tissue expression.
Wang Y; Li J; Yan Kwok AH; Ge W; Leung FC
Gen Comp Endocrinol; 2010 Mar; 166(1):200-10. PubMed ID: 19854191
[TBL] [Abstract][Full Text] [Related]
40. Temporal and spatial regulation of integrin vitronectin receptor mRNAs in the embryonic chick retina.
Gervin DB; Cann GM; Clegg DO
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1084-96. PubMed ID: 8631624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
